Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients
Autor: | Laurent Possenti, Christophe Cassinotto, Arnaud Hocquelet, Jean-Frédéric Blanc, Pierre Balageas, Jean Saric, Hervé Trillaud, Michel Montaudon, Pierre-Henri Bernard, Nora Frulio, Cécile Salut, Christophe Laurent |
---|---|
Rok vydání: | 2015 |
Předmět: |
Surgical resection
Male Cancer Research medicine.medical_specialty Carcinoma Hepatocellular Physiology Radiofrequency ablation Milan criteria Disease-Free Survival law.invention law Physiology (medical) Medicine Humans Major complication Aged Probability Retrospective Studies business.industry Proportional hazards model Confounding Liver Neoplasms Middle Aged medicine.disease Surgery Pulsed Radiofrequency Treatment Hepatocellular carcinoma Propensity score matching Disease Progression Female Radiology business |
Zdroj: | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 31(7) |
ISSN: | 1464-5157 |
Popis: | The aim of this study was to compare survival between radiofrequency ablation (RFA) and surgical resection (SR) in patients with hepatocellular carcinoma (HCC) within Milan criteria.From January 2004 to December 2013 we consecutively and retrospectively included all patients with first occurrence of HCC within Milan criteria receiving SR or RFA as first-line treatment. The cumulative overall survival (OS) and disease-free survival (DFS) were compared after inverse probability weighting (including confounding factor).A total of 281 patients (RFA 178, SR 103) were enrolled. In multivariate Cox regression RFA and SR were not independent predictors of survival or recurrence. The respective weighted 5 years OS and DFS for patients with propensity scores between 0.1-0.9 in the SR and RFA groups were 54-33% and 60-16.9%, P = 0.695 and P = 0.426, respectively. Local tumour progression rate did not differ according to treatment (P = 0.523). Major complication rate was higher in the SR group, P = 0.001. Hospitalisation duration was lower in the RFA group (mean 2.19 days, range 2-7) than in the SR group (mean 10.2 days, range 3-30), P0.001.This large Western study has shown that OS and DFS did not differ after RFA (using mainly multipolar devices) and SR, for HCC within the Milan criteria in a European population, with a shorter hospitalisation time and a lower complication rate for RFA. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |